Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Barbara Ann Karmanos Cancer Institute Identifier:
First received: December 10, 1999
Last updated: April 22, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)